查看購物車
  • Simplified Chinese
  • English
歐洲腸內營養市場規模及預測 2021-2031、區域佔有率、趨勢及成長機會分析報告範圍：依產品類型（鼻胃管、鼻腸管、吸飲管及其他）及國家/地區
市場調查報告書
商品編碼
1646530

歐洲腸內營養市場規模及預測 2021-2031、區域佔有率、趨勢及成長機會分析報告範圍：依產品類型（鼻胃管、鼻腸管、吸飲管及其他）及國家/地區

Europe Enteral Nutrition Market Size and Forecast 2021-2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Nasogastric, Nasoenteral, Sipping, and Others) and Country
出版日期: | 出版商: The Insight Partners | 英文 124 Pages | 訂單完成後即時交付

價格

歐洲腸內營養市場規模預計將從 2023 年的 33.2 億美元增至 2031 年的 57.9 億美元。

標準化配方和植物營養產品

消費者對幫助主動管理健康的產品的需求激增，尤其是那些專注於能量水平、免疫力和疾病治療方面的特定需求的產品。腸內產品的功能和特定配方不會干擾患者現有的治療。腸內營養的常量營養素和微量營養素配方及其應用根據所考慮的疾病而有所不同。等熱量腸內營養配方（1 kcal/ml）通常用於實現估計或測量的熱量目標，而高能量配方（>1 kcal/ml）則用於增加胃腸功能障礙患者的熱量輸送。

標準化的腸內營養產品含有固定的成分，旨在滿足患者的平均營養需求，同時考慮到不同年齡層患者的需求不同。例如，Peptamen Formula（雀巢）是唯一含有酵素水解 100% 乳清蛋白的胜肽基配方，有助於克服管飼不耐症。此類管飼配方是專門的腸內營養產品，旨在支持患有胃腸道疾病的患者的吸收並克服耐受機制。

越來越多的人開始選擇植物性食物，引發了全球對植物性營養產品的需求。人們對大量使用的人工/合成成分的耐受性越來越差，因為這可能會引發不良反應。 2020 年 Innova 消費者調查顯示，健康、飲食多樣性、永續性和口味是人們考慮植物性替代品的主要原因。雅培表示，消費者和依賴管飼的患者也非常關注這些參數。歐洲腸內營養市場的公司正在利用各個人口群體對健康食品日益成長的偏好來獲利。因此，Kate Farms、Functional Formularies 和 Real Food Blends 等公司開發了更多天然、植物性的腸內產品。 2021 年 8 月，Kate Farms 推出了首個封閉式餵食系統，以 1 公升容量的即掛袋形式提供植物配方奶粉。 Kate Farms Standard 1.4 純天然配方和 Peptide 1.5 純天然配方是植物性、有機、熱量密集產品，可作為管飼中補充營養的唯一來源。 2021 年 9 月，雅培針對兒童和成人推出了一系列植物性蛋白質和有機食品成分。

因此，功能性、以患者為中心的配方和植物性營養產品是歐洲腸內營養市場的主要新興趨勢。

法國腸道營養市場分析

根據 2023 年 3 月《世界報》發表的一篇文章，法國 60 歲及以上人口的比例預計將從 2023 年的約 20% 飆升至 2050 年的約 30%。 2030-2050 年期間將達到近90%。老年人常患有糖尿病、心血管疾病和神經系統疾病（例如中風、帕金森氏症和阿茲海默症）等慢性疾病。這些情況會損害正常進食能力，導致營養不良並需要腸內餵食。根據全球癌症觀察站統計，2022年法國通報癌症新發病例483,568例，患病病例數（5年）為1,494,814例。癌症與腸內營養有密切關係。許多癌症患者因疾病本身或接受的治療而營養不良，這會損害他們進食和吸收必需營養素的能力。

Fresenius Kabir France 提供多樣化的即用型腸內營養產品，如管飼、口服營養補充劑 (ONS) 和粉末產品。針對吞嚥困難患者，該公司提供不同濃稠度的質地改良產品，以滿足不同患者的個人需求。

歐洲腸內營養市場報告細分分析

有助於得出歐洲腸內營養市場分析的關鍵部分是類型、材料和最終用戶。

根據產品類型，歐洲腸內營養市場分為鼻胃管、鼻腸管、吸入管和其他管。 2023 年，鼻胃管領域佔據了市場的最大佔有率。

歐洲腸內營養市場的一些知名企業包括雀巢、達能公司、雅培實驗室、菲仕蘭坎皮納、費森尤斯集團、貝朗公司、Dr. Schar AG、Arla Food、利潔時、百利戈公司、其中包括恆天然合作Group Limited、Kate Farms 和 Nutritional Medicinals, LLC。

公司正在推出新的創新產品和服務，以維持其在歐洲腸內營養市場的地位。 2021年11月，雅培推出 Similac 360 Total Care，支持免疫系統、消化系統健康和大腦發展。 Similac 360 Total Care 是美國第一款也是唯一一款混合了五種不同 HMO 的嬰兒配方奶粉，此前這些 HMO 僅在母乳中同時存在。此配方奶粉旨在提供營養以支持嬰兒的整個健康和發育，包括正在發育的免疫系統、消化系統和大腦。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 發育基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：歐洲腸內營養市場格局

  • 概述
  • PEST分析
  • 定價分析
  • 飲水配方定價分析
  • 五大市場主要參與者名單
    • 德國、法國、英國的主要市場參與者

第 5 章：歐洲腸內營養市場 - 主要市場動態

  • 歐洲腸內營養市場 - 主要市場動態
  • 市場促進因素
    • 胃腸道疾病發生率不斷上升
    • 營養不良和早產病例增加
  • 市場限制
    • 與餵食系統相關的機械、胃腸道和代謝併發症
  • 市場機會
    • 主要市場參與者的策略性舉措
  • 未來趨勢
    • 標準化配方和植物營養產品
  • 促進因素和限制因素的影響：

第 6 章：歐洲腸內營養市場分析

  • 2021 至 2031 年歐洲腸內營養市場收入
  • 歐洲腸內營養市場預測與分析
  • 腸內和腸外市場價值 (%)

第 7 章：歐洲腸內營養市場分析 - 依產品類型

  • 鼻胃管
  • 經鼻腸
  • 啜飲
  • 其他

第 8 章：歐洲腸內營養市場-國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 捷克共和國
    • 歐洲其他地區

第9章：產業格局

  • 概述
  • 歐洲腸內營養市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第10章：公司簡介

  • Nestle SA
  • Danone SA
  • Abbott Laboratories
  • Royal FrieslandCampina NV
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Reckitt Benckiser Group Plc
  • Kate Farms Inc
  • Dr Schar AG
  • Fonterra Co-Operative Group Ltd
  • Arla Foods amba
  • Perrigo Co Plc
  • Charing Cross Scientific AS
  • Bexen Medical

第 11 章：附錄

Product Code: TIPRE00039375

The Europe enteral nutrition market size is projected to reach US$ 5.79 billion by 2031 from US$ 3.32 billion in 2023. The market is expected to register a CAGR of 7.2% during 2023-2031.

Standardized Formulations and Plant-Based Nutrition Products

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Functionality and specific formulations of enteral products do not interfere with the existing treatments of patients. The macro-nutrient and micronutrient formulations of enteral nutrition and their applications vary based on the disease under consideration. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction.

Standardized enteral nutrition products contain fixed constituents and are designed to meet the average nutritional requirements of patients, considering that the requirements differ in different age groups. For example, Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders.

A surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are becoming increasingly intolerant of artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. Abbott states that consumers and patients relying on tube feeding also pay much attention to these parameters. Companies in the Europe enteral nutrition market are capitalizing on the growing preference for healthy foods in various demographic groups. As a result, companies such as Kate Farms, Functional Formularies, and Real Food Blends have developed more natural, plant-based enteral products. In August 2021, Kate Farms launched the first closed feeding system delivering plant-based formulas in ready-to-hang bags of 1 L capacity. Kate Farms Standard 1.4 plain and Peptide 1.5 plain formulations are plant-based, organic, calorically dense products that are used as a sole source of supplemental nutrition in tube feeding. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults.

Therefore, functional, patient-centric formulations and plant-based nutrition products are the prime emerging trends in the Europe enteral nutrition market.

France Enteral Nutrition Market Analysis

According to a Le Monde article published in March 2023, the population share of people aged 60 or more in France is expected to surge from ~20% in 2023 to ~30% by 2050. The number of people aged 85 and above would grow by nearly 90% during 2030-2050. Older adults often experience chronic conditions such as diabetes, cardiovascular diseases, and neurological disorders (e.g., stroke, Parkinson's disease, and Alzheimer's). These conditions can impair the ability to eat normally, leading to malnutrition and requiring enteral feeding. According to the Global Cancer Observatory, France reported 483,568 new cancer cases in 2022, and the number of prevalent cases (5-year) was 1,494,814. Cancer and enteral nutrition are closely connected. Many cancer patients suffer from malnutrition due to the disease itself or the treatments they receive, which can impair their ability to eat and absorb essential nutrients.

Fresenius Kabir France offers a diverse portfolio of ready-to-use enteral nutrition products such as tube feeds, oral nutritional supplements (ONS), and powder products. For patients with dysphagia, the company offers texture-modified products in different consistencies to meet the individual needs of different patients.

Europe Enteral Nutrition Market Report Segmentation Analysis

Key segments that contributed to the derivation of the Europe enteral nutrition market analysis are type, material, and end user.

Based on product type, the Europe enteral nutrition market is segmented into Nasogastric, Nasoenteral, Sipping and Others. The nasogastric segment held the largest share of the market in 2023.

A few prominent players operating in the Europe enteral nutrition market are Nestle, Danone S.A., Abbott Laboratories, Friesland Campina, Fresenius SE and Co. KGaA, B. Braun SE, Dr. Schar AG, Arla Food, Reckitt Benckiser, Perrigo Company PLC, Fonterra Co-operative Group Limited, Kate Farms, and Nutritional Medicinals, LLC among others.

Companies are launching new and innovative products and services to sustain their position in the Europe enteral nutrition market size. In November 2021, Abbott Launched Similac 360 Total Care to Support the Immune System, Digestive Health, and Brain Development. Similac 360 Total Care is the first and only infant formula in the U.S. with a blend of five different HMOs, previously only found together in breast milk. This formula is designed to provide nutrition to support the whole baby's health and development, including the developing immune system, digestive system, and brain.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Enteral Nutrition Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Pricing Analysis
  • 4.4 Pricing Analysis for Sipping Formula
  • 4.5 List of Key Market Players in Top 5 Market
    • 4.5.1 Major Market players in Germany, France, United Kingdom

5. Europe Enteral Nutrition Market - Key Market Dynamics

  • 5.1 Europe Enteral Nutrition Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Gastrointestinal Diseases
    • 5.2.2 Rising Cases of Malnutrition and Premature Births
  • 5.3 Market Restraints
    • 5.3.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Feeding Systems
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Key Market Players
  • 5.5 Future Trends
    • 5.5.1 Standardized Formulations and Plant-Based Nutrition Products
  • 5.6 Impact of Drivers and Restraints:

6. Europe Enteral Nutrition Market Analysis

  • 6.1 Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Enteral Nutrition Market Forecast and Analysis
  • 6.3 Enteral and Parenteral Market Value (%)

7. Europe Enteral Nutrition Market Analysis - by Product Type

  • 7.1 Nasogastric
    • 7.1.1 Overview
    • 7.1.2 Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    • 7.1.3 Standard
      • 7.1.3.1 Overview
      • 7.1.3.2 Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
    • 7.1.4 Disease Specific
      • 7.1.4.1 Overview
      • 7.1.4.2 Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Nasoenteral
    • 7.2.1 Overview
    • 7.2.2 Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Sipping
    • 7.3.1 Overview
    • 7.3.2 Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Enteral Nutrition Market - Country Analysis

  • 8.1 Europe
    • 8.1.1 Europe Enteral Nutrition Market Breakdown by Countries
    • 8.1.2 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
      • 8.1.2.1 Europe Enteral Nutrition Market Revenue and Forecast and Analysis - by Country
      • 8.1.2.2 Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.2.1 Germany: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.2.2 Germany: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.2.3 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.2.4 Germany: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.2.5 Germany: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.2.6 Germany: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.2.7 Germany: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.3 United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.3.1 United Kingdom: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.3.2 United Kingdom: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.3.3 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.3.4 United Kingdom: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.3.5 United Kingdom: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.3.6 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.3.7 United Kingdom: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.4 France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.4.1 France: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.4.2 France: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.4.3 France: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.4.4 France: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.4.5 France: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.4.6 France: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.4.7 France: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.5 Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.5.1 Italy: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.5.2 Italy: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.5.3 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.5.4 Italy: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.5.5 Italy: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.5.6 Italy: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.5.7 Italy: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.6 Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.6.1 Spain: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.6.2 Spain: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.6.3 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.6.4 Spain: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.6.5 Spain: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.6.6 Spain: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.6.7 Spain: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.7 Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.7.1 Czech Republic: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.7.2 Czech Republic: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.7.3 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.7.4 Czech Republic: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.7.5 Czech Republic: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.7.6 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.7.7 Czech Republic: Europe Enteral Nutrition Market Breakdown by Standard By End User
      • 8.1.2.8 Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.2.8.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Product Type
        • 8.1.2.8.2 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Nasogastric Type
        • 8.1.2.8.3 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Calories
        • 8.1.2.8.4 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Isocaloric
        • 8.1.2.8.5 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Hypercaloric
        • 8.1.2.8.6 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By Type
        • 8.1.2.8.7 Rest of Europe: Europe Enteral Nutrition Market Breakdown by Standard By End User

9. Industry Landscape

  • 9.1 Overview
  • 9.2 Growth Strategies in Europe Enteral Nutrition Market
  • 9.3 Organic Growth Strategies
    • 9.3.1 Overview
  • 9.4 Inorganic Growth Strategies
    • 9.4.1 Overview

10. Company Profiles

  • 10.1 Nestle SA
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Danone SA
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Abbott Laboratories
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Royal FrieslandCampina NV
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Fresenius SE & Co KGaA
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 B Braun SE
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Reckitt Benckiser Group Plc
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Kate Farms Inc
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Dr Schar AG
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Fonterra Co-Operative Group Ltd
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments
  • 10.11 Arla Foods amba
    • 10.11.1 Key Facts
    • 10.11.2 Business Description
    • 10.11.3 Products and Services
    • 10.11.4 Financial Overview
    • 10.11.5 SWOT Analysis
    • 10.11.6 Key Developments
  • 10.12 Perrigo Co Plc
    • 10.12.1 Key Facts
    • 10.12.2 Business Description
    • 10.12.3 Products and Services
    • 10.12.4 Financial Overview
    • 10.12.5 SWOT Analysis
    • 10.12.6 Key Developments
  • 10.13 Charing Cross Scientific AS
    • 10.13.1 Key Facts
    • 10.13.2 Business Description
    • 10.13.3 Products and Services
    • 10.13.4 Financial Overview
    • 10.13.5 SWOT Analysis
    • 10.13.6 Key Developments
  • 10.14 Bexen Medical
    • 10.14.1 Key Facts
    • 10.14.2 Business Description
    • 10.14.3 Products and Services
    • 10.14.4 Financial Overview
    • 10.14.5 SWOT Analysis
    • 10.14.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Enteral Nutrition Market Segmentation
  • Table 2. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 4. Sipping: Europe Enteral Nutrition Market, By Type (US$ Mn)
  • Table 5. Sipping: Europe Enteral Nutrition Market, By Standadr by Calories (US$ Mn)
  • Table 6. Sipping: Europe Enteral Nutrition Market, By Isocaloric (US$ Mn)
  • Table 7. Sipping: Europe Enteral Nutrition Market, By Hypercaloric (US$ Mn)
  • Table 8. Sipping: Europe Enteral Nutrition Market, By Standard by Type (US$ Mn)
  • Table 9. Sipping: Europe Enteral Nutrition Market, By Standard End User (US$ Mn)
  • Table 10. Sipping: Top 5 Europe Enteral Nutrition Markets (US$ Mn)
  • Table 11. Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Country
  • Table 12. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 13. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 14. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 15. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 16. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 17. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 18. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 19. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 20. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 21. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 22. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 23. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 24. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 25. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 26. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 27. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 28. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 29. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 30. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 31. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 32. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 33. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 34. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 35. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 36. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 37. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 38. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 39. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 40. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 41. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 42. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 43. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 44. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 45. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 46. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 47. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 48. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 49. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 50. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 51. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 52. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 53. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 54. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
  • Table 55. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Nasogastric Type
  • Table 56. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Calories
  • Table 57. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Isocaloric
  • Table 58. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Hypercaloric
  • Table 59. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By Type
  • Table 60. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million) - by Standard By End User
  • Table 61. Recent Organic Growth Strategies in Europe Enteral Nutrition Market
  • Table 62. Recent Inorganic Growth Strategies in the Europe Enteral Nutrition Market
  • Table 63. Glossary of Terms, Europe Enteral Nutrition Market

List Of Figures

  • Figure 1. Europe Enteral Nutrition Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Enteral Nutrition Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Enteral Nutrition Market Share (%) - by Product Type, 2023 and 2031
  • Figure 6. Nasogastric: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Standard: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Disease Specific: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Nasoenteral: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Sipping: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Others: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Europe Enteral Nutrition Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 13. Germany: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. United Kingdom: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. France: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Italy: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Spain: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Czech Republic: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Rest of Europe: Europe Enteral Nutrition Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Growth Strategies in Europe Enteral Nutrition Market